Ramesh Thurairaja
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, Southmead Hospital, Age UK
Papers
18
Total Citations
644
H-Index
9
About
Ramesh Thurairaja is a leading urological surgeon whose research has fundamentally shaped the modern surgical management of bladder cancer. His work centers on the comparative effectiveness of robot-assisted radical cystectomy (RARC) versus open surgery, with a particular focus on the transition to totally intracorporeal urinary diversion. His landmark 2022 JAMA study (320 citations) demonstrated that robot-assisted cystectomy with intracorporeal diversion does not significantly reduce 90-day morbidity compared to open surgery, providing crucial evidence for surgical decision-making. He also led the CORAL trial, which reported long-term oncological outcomes across open, robotic, and laparoscopic approaches. Thurairaja has systematically evaluated the safety and efficiency of transitioning from extracorporeal to intracorporeal diversion, publishing a widely-cited "recipe" for reducing operative time and complications. His work extends to health economics, with a 2023 cost-effectiveness analysis (26 citations) informing payer perspectives on robotic surgery. Through national analyses of over 12,000 cystectomies in England, he has documented real-world adoption trends and postoperative outcomes. Thurairaja’s contributions have helped define the evidence base for minimally invasive bladder cancer surgery, guiding both clinical practice and health policy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Bladder cancer32 citations · 2019
- 5
- 6
- 7
- 8
- 9
- 10